Using genomics to identify new targets and counteract resistance to antibiotics

Bibliography

• VICENTE M, HODGSON J, MASSIDDA O et al.: The fallacies of hope: will we discover new antibiotics to combat pathogenic bacteria in time? FEMS Microbiol. Rev. (2006) 30(6):841-852.
   PubMed Web of Science ®Google Scholar
• WAKSMAN SA, WOODRUFF HB: Selective antibiotic action of various substances of microbial origin. J. Bacteriol. (1942) 44(3):373-384.
   PubMedGoogle Scholar
• WALSH C: Where will new antibiotics come from? Nat. Rev. Microbiol. (2003) 1(1):65-70.
   PubMed Web of Science ®Google Scholar
• LEVY SB, MARSHALL B: Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. (2004) 10(Suppl. 12):S122-S129.
   PubMed Web of Science ®Google Scholar
• LIVERMORE DM: Bacterial resistance: origins, epidemiology, and impact. Clin. Infect. Dis. (2003) 36(Suppl. 1):S11-S23.
   PubMed Web of Science ®Google Scholar
• PATERSON DL: Clinical experience with recently approved antibiotics. Curr. Opin. Pharmacol. (2006) 6(5):486-490.
   PubMed Web of Science ®Google Scholar
• MOELLERING RC: Linezolid: the first oxazolidinone antimicrobial. Ann. Intern. Med. (2003) 138(2):135-142.
   PubMed Web of Science ®Google Scholar
• LAPLANTE KL, RYBAK MJ: Daptomycin – a novel antibiotic against gram-positive pathogens. Expert Opin. Pharmacother. (2004) 5(11):2321-2331.
   PubMed Web of Science ®Google Scholar
• ROSE WE, RYBAK MJ: Tigecycline: first of a new class of antimicrobial agents. Pharmacotherapy (2006) 26(8):1099-1110.
   PubMed Web of Science ®Google Scholar
• RITTENHOUSE S, BISWAS S, BROSKEY J et al.: Selection of retapamulin, a novel pleuromutilin for topical use. Antimicrob. Agents Chemother. (2006) 50(11):3882-3885.
   PubMed Web of Science ®Google Scholar
• CHAN PF, MACARRON R, PAYNE DJ, ZALACAIN M, HOLMES DJ: Novel antibacterials: a genomics approach to drug discovery. Curr. Drug Targets Infect. Disord. (2002) 2(4):291-308.
   PubMedGoogle Scholar
• FREIBERG C, BROTZ-OESTERHELT H,LABISCHINSKI H: The impact of transcriptome and proteome analyses on antibiotic drug discovery. Curr. Opin. Microbiol. (2004) 7(5):451-459.
   PubMed Web of Science ®Google Scholar
• RUSH TS III, GRANT JA, MOSYAK L, NICHOLLS A: A shape-based 3-D scaffold hopping method and its application to a bacterial protein–protein interaction. J. Med. Chem. (2005) 48(5):1489-1495.
   PubMed Web of Science ®Google Scholar
• ZALACAIN M et al.: A global approach to identify novel broad-spectrum antibacterial targets among proteins of unknown function. J. Mol. Microbiol. Biotechnol. (2003) 6(2):109-126.
   PubMed Web of Science ®Google Scholar
• D’COSTA VM, MCGRANN KM, HUGHES DW, WRIGHT GD: Sampling the antibiotic resistome. Science (2006) 311(5759):374-377.
   PubMed Web of Science ®Google Scholar
• FLEISCHMANN RD, ADAMS MD, WHITE O et al.: Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science (1995) 269(5223):496-512.
   PubMed Web of Science ®Google Scholar
• BLATTNER FR, PLUNKETT G 3RD, BLOCH CA et al.: The complete genome sequence of Escherichia coli K-12. Science (1997) 277(5331):1453-1474.
   PubMed Web of Science ®Google Scholar
• PERNA NT, PLUNKETT G III, BURLAND V et al.: Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature (2001) 409(6819):529-533.
   PubMed Web of Science ®Google Scholar
• VENTER JC, ADAMS MD, MYERS EW et al.: The sequence of the human genome. Science (2001) 291(5507):1304-1351.
   PubMed Web of Science ®Google Scholar
• LANDER ES, LINTON LM, BIRREN B et al.: Initial sequencing and analysis of the human genome. Nature (2001) 409(6822):860-921.
   PubMed Web of Science ®Google Scholar
• GERSTEIN M, JANSEN R: The current excitement in bioinformatics-analysis of whole-genome expression data: how does it relate to protein structure and function? Curr. Opin. Struct. Biol. (2000) 10(5):574-584.
   PubMed Web of Science ®Google Scholar
• ROSAMOND J, ALLSOP A: Harnessing the power of the genome in the search for new antibiotics. Science (2000) 287(5460):1973-1976.
   PubMed Web of Science ®Google Scholar
• PUCCI MJ: Use of genomics to select antibacterial targets. Biochem. Pharmacol. (2006) 71(7):1066-1072.
   PubMed Web of Science ®Google Scholar
• HENSEL M, SHEA JE, GLEESON C et al.: Simultaneous identification of bacterial virulence genes by negative selection. Science (1995) 269(5222):400-403.
   PubMed Web of Science ®Google Scholar
• MAHAN MJ, SLAUCH JM, MEKALANOS JJ: Selection of bacterial virulence genes that are specifically induced in host tissues. Science (1993) 259(5095):686-688.
   PubMed Web of Science ®Google Scholar
• VALDIVIA RH, FALKOW S: Fluorescence-based isolation of bacterial genes expressed within host cells. Science (1997) 277(5334):2007-2011.
   PubMed Web of Science ®Google Scholar
• LIPINSKI CA, LOMBARDO F, DOMINY BW, FEENEY PJ: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. (2001) 46(1-3):3-26.
   PubMed Web of Science ®Google Scholar
• PAYNE DJ, GWYNN MN, HOLMES DJ, POMPLIANO DL: Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. (2007) 6(1):29-40.
   PubMed Web of Science ®Google Scholar
• BUTLER SM, FESTA RA, PEARCE MJ, DARWIN KH: Self-compartmentalized bacterial proteases and pathogenesis. Mol. Microbiol. (2006) 60(3):553-562.
   PubMed Web of Science ®Google Scholar
• BROTZ-OESTERHELT H, BEYER D, KROLL HP et al.: Dysregulation of bacterial proteolytic machinery by a new class of antibiotics. Nat Med. (2005) 11(10):1082-1087.
   PubMed Web of Science ®Google Scholar
• DREWS J: Genomic sciences and the medicine of tomorrow. Nat. Biotechnol. (1996) 14(11):1516-1518.
   PubMed Web of Science ®Google Scholar
• PAYNE: Will genomics, high throughput screening deliver new anti-infectives in a cost effective way? 7^th European Congress of Chemotherapy and Infection. Florence, Italy (2005):S23.3.
   Google Scholar
• LOVERING AL, DE CASTRO LH, LIM D, STRYNADKA NC: Structural insight into the transglycosylation step of bacterial cell-wall biosynthesis. Science (2007) 315(5817):1402-1405.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI K, EHRLICH SD, ALBERTINI A et al.: Essential Bacillus subtilis genes. Proc. Natl. Acad. Sci. USA (2003) 100(8):4678-4683.
   PubMed Web of Science ®Google Scholar
• SALAMA NR, SHEPHERD B, FALKOW S: Global transposon mutagenesis and essential gene analysis of Helicobacter pylori. J. Bacteriol. (2004) 186(23):7926-7935.
   PubMed Web of Science ®Google Scholar
• THANASSI JA, HARTMAN-NEUMANN SL, DOUGHERTY TJ, DOUGHERTY BA, PUCCI MJ: Identification of 113 conserved essential genes using a high-throughput gene disruption system in Streptococcus pneumoniae. Nucleic Acids Res. (2002) 30(14):3152-3162.
   PubMed Web of Science ®Google Scholar
• FORSYTH RA, HASELBECK RJ, OHLSEN KL et al.: A genome-wide strategy for the identification of essential genes in Staphylococcus aureus. Mol. Microbiol. (2002) 43(6):1387-1400.
   PubMed Web of Science ®Google Scholar
• GERDES SY, SCHOLLE MD, CAMPBELL JW et al.: Experimental determination and system level analysis of essential genes in Escherichia coli MG1655. J. Bacteriol. (2003) 185(19):5673-5684.
   PubMed Web of Science ®Google Scholar
• HUTCHISON CA, PETERSON SN, GILL SR et al.: Global transposon mutagenesis and a minimal Mycoplasma genome. Science (1999) 286(5447):2165-2169.
   PubMed Web of Science ®Google Scholar
• AKERLEY BJ, RUBIN EJ, CAMILLI A et al.: Systematic identification of essential genes by in vitro mariner mutagenesis. Proc. Natl. Acad. Sci. USA (1998) 95(15):8927-8932.
   PubMed Web of Science ®Google Scholar
• KU YW, MCDONOUGH SP, PALANIAPPAN RU, CHANG CF, CHANG YF: Novel attenuated Salmonella enterica serovar Choleraesuis strains as live vaccine candidates generated by signature-tagged mutagenesis. Infect. Immunol. (2005) 73(12):8194-8203.
   PubMed Web of Science ®Google Scholar
• LEHOUX DE, LEVESQUE RC: Detection of genes essential in specific niches by signature-tagged mutagenesis. Curr. Opin. Biotechnol. (2000) 11(5):434-439.
   PubMed Web of Science ®Google Scholar
• PAIK S, SENTY L, DAS S et al.: Identification of virulence determinants for endocarditis in Streptococcus sanguinis by signature-tagged mutagenesis. Infect. Immunol. (2005) 73(9):6064-6074.
   PubMed Web of Science ®Google Scholar
• STRUVE C, FORESTIER C, KROGFELT KA: Application of a novel multi-screening signature-tagged mutagenesis assay for identification of Klebsiella pneumoniae genes essential in colonization and infection. Microbiology (2003) 149(Pt 1):167-176.
   PubMed Web of Science ®Google Scholar
• ZYGMUNT MS, HAGIUS SD, WALKER JV, ELZER PH: Identification of Brucella melitensis 16M genes required for bacterial survival in the caprine host. Microbes Infect. (2006) 8(14-15):2849-2854.
   PubMed Web of Science ®Google Scholar
• DIMASI JA, HANSEN RW, GRABOWSKI HG: The price of innovation: new estimates of drug development costs. J. Health Econ. (2003) 22(2):151-185.
   PubMed Web of Science ®Google Scholar